References
- The US Food and Drug Administration. What Are Generic Drugs?. Silver Spring (MD): US Department of Health & Human Services, 2009. Available at: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/ucm144456.htm [Last accessed 12 May 2010]
- The US Food and Drug Administration. Generic Drugs: Questions and Answers. US Department of Health & Human Services, 2010. Available at: http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm134147.htm [Last accessed 12 May 2010]
- The US Food and Drug Administration. Facts and Myths about Generic Drugs. US Department of Health & Human Services, 2009. Available at: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/ucm167991.htm [Last accessed 12 May 2010]
- The US Food and Drug Administration. Generic Drugs: What You Need to Know. Silver Spring (MD): US Department of Health & Human Services, 2009. Available at: http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm134451.htm [Last accessed 12 May 2010]
- Nelson A. Difference Between Generic Drug And Branded Drugs. Sooperarticles. Available at: http://www.sooperarticles.com/health-fitness-articles/drugs-articles/difference-between-generic-drug-branded-drugs-150744.html [Last accessed 9 January 2010]
- Depression and Bipolar Support Alliance. Generic and Brand Name Drugs: Understanding the Basics. Chicago, Illinois: Depression and Bipolar Support Alliance, c2007. Available at: http://www.dbsalliance.org/pdfs/GenericRx.pdf [Last accessed 23 August 2009]
- Dighe SV. A Review of the Safety of Generic Drugs. Transplant P. 1999;31:23S-24S
- The US Food and Drug Administration. Sec. 505. [21 USC §355] New Drugs. Silver Spring (MD): US Department of Health & Human Services, 2009. Available at: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/FDCActChapterVDrugsandDevices/ucm108125.htm [Last accessed 15 May 2010]
- IPpro Services (India) Pvt. Ltd. Hatch–Waxman Act and Paragraph IV Litigations. IPpro Inc., c2008. Available at: http://www.ipproinc.com/admin/uploads/Hatch–Waxman_Act_And_Para_IV_Filing_-_Feb_58.pdf [Last accessed 19 June 2010]
- Schacht WH, Thomas JR. The Hatch–Waxman Act: Selected Patent-Related Issues. Washington DC: National Council for Science and The Environment, 2002. Congressional Research Service Report RL31379. Available at: http://wikileaks.org/wiki/CRS-RL31379 [Last accessed 12 April 2010]
- The US Food and Drug Administration. Guidance for Industry 180-Day Generic Drug Exclusivity under the Hatch–Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. Silver Spring (MD): US Department of Health & Human Services, 1998. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/ucm079342.pdf [Last accessed 26 May 2010]
- United States Patent and Trademark Office. 35 USC 156 Extension of patent term – Patent Laws. Alexandria (VA): US Department of Commerce, 2008. Available at: http://www.uspto.gov/web/offices/pac/mpep/documents/appxl_35_U_S_C_156.htm [Last accessed 15 May 2010]
- The US Food and Drug Administration. Greater Access to Generic Drugs. Silver Spring (MD): US Department of Health & Human Services, 2010. Available at: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143545.htm [Last accessed 6 September 2010]
- Randall IV B, The US Drug Approval Process A Primer. Washington DC: National Council for Science and The Environment, 2002. Congressional Research Service Report RL30989. Available at: http://www.law.umaryland.edu/marshall/crsreports/crsdocuments/RL30989.pdf [Last accessed 20 May 2010]
- Guidance for Industry (M4: Organization of the CTD). Silver Spring (MD): US Department of Health & Human Services, 2001. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073257.pdf [Last accessed 26 May 2010]
- Raw AS et al. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Adv Drug Deliver Rev. 2004;56:397-414
- The US Food and Drug Administration. Pharmaceutical Quality for the 21st Century A Risk-Based Approach Progress Report. Silver Spring (MD): US Department of Health & Human Services, 2009. Available at: http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm128080.htm [Last accessed 6 July 2010]
- Yu LX et al. US FDA question-based review for generic drugs: A new pharmaceutical quality assessment system. J Generic Medicines. 2007;4:239-48
- The US Food and Drug Administration. The FDA’s Drug Review Process: Ensuring Drugs Are Safe and Effective. Silver Spring (MD): US Department of Health & Human Services, 2010. Available at: http://www.fda.gov/drugs/resourcesforyou/consumers/ucm143534.htm [Last accessed 20 April 2010]